Edwards Lifesciences EW Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 77.9%-1.6pp | 78%-1.4pp | 78.2%-1.6pp | 78.9%-0.7pp | 79.5%-0.1pp | |
| Operating margin | 21.4%-4.4pp | 20.8%-4.5pp | 24.2%-2.3pp | 25.8%-1.6pp | 25.8%-0.1pp | |
| Net margin | 17.4%-58.3pp | 17.7%-59.1pp | 23.2%-54.9pp | 73%+44.7pp | 75.7%+48.1pp | |
| Returns | ||||||
| Return on equity | 10.7%-37.8pp | 10.6%-39.6pp | 13.9%-37.5pp | 46.1%+24.8pp | 48.5%+26.9pp | |
| Return on invested capital | 13.7%-4.1pp | 13.3%-4.7pp | 16.4%-4.1pp | 17.6%-3.0pp | 17.8%-1.3pp | |
| Efficiency | ||||||
| Asset turnover | 0.5×0.0× | 0.5×0.0× | 0.4×0.0× | 0.5×-0.1× | 0.5×-0.1× | |
| Liquidity | ||||||
| Current ratio | 4.4×0.0× | 3.7×-0.5× | 4×+0.5× | 4.7×+1.0× | 4.5×+0.7× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Net debt / EBITDA | -1.2×+0.4× | -1.6×0.0× | -1.3×+0.6× | -1.6×-1.0× | -1.6×-1.2× | |
| Per Share | ||||||
| Book value per share | $17.78+3.2% | $17.65+5.8% | $17.42+9.2% | $17.94+45.7% | $17.23+46.2% | |
| Valuation | ||||||
| Market capitalization | $46.17B+8.7% | $49.47B+13.3% | $45.66B+14.9% | $44.49B-20.1% | $42.46B-26.2% | |
| Price / earnings | 42.1×+32.0× | 46.1×+35.6× | 33.4×+23.8× | 10.7×-27.1× | 10.2×-30.5× | |
| Price / sales | 7.3×-0.4× | 8.2×+0.1× | 7.8×+0.3× | 7.8×-2.9× | 7.7×-3.5× | |
| Price / book | 4.5×+0.3× | 4.8×+0.4× | 4.5×+0.3× | 4.2×-3.3× | 4.2×-3.9× | |
| EV / EBITDA | 29.5×+4.1× | 33.2×+6.3× | 27.6×+4.1× | 25.9×-8.8× | 25.4×-13.3× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Edwards Lifesciences's profit margins?
- Edwards Lifesciences (EW) runs a 77.9% gross margin and a 21.4% operating margin, with a 17.4% net margin.
- Where do Edwards Lifesciences's ratios come from?
- Every ratio is computed from Edwards Lifesciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
